www.fdanews.com/articles/149211-valeant-revives-growth-plan-with-2-6-billion-medicis-deal

Valeant Revives Growth Plan With $2.6 Billion Medicis Deal

September 5, 2012

Valeant Pharmaceuticals’ $2.6 billion agreement to buy skin-care company Medicis Pharmaceutical recharges an acquisition plan that stumbled with last year’s failed bid for Cephalon.
San Francisco Chronicle